Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Biosimilars

Research Grade Tefibazumab (JN060016)

Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview
  • Images
  • References
  • Datasheet
Overview
Catalog No.JN060016
Species reactivityStaphylococcus aureus
ApplicationsELISA, Functional assay, Research in vivo
Host speciesHumanized
IsotypeIgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target clfAClumping factor A
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q53653, Q2G015, Q5HHM8
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate NamesAurexis, 521079-87-8
BackgroundTefibazumab is a humanized IgG1κ monoclonal antibody that binds to the surface-expressed adhesion protein clumping factor A. Tefibazumab can be used for the research of serious Staphylococcus aureus infections.
• Diabetic retinopathy., PMID:22455417
• Novel Target for Limiting VEGF-A (Vascular Endothelial Growth Factor A)-Induced Vascular Permeability., PMID:36004641
• Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis., PMID:32654325
• Interleukin-37, vascular endothelial growth factor A, and transforming growth factor-β1: promising biomarkers in primary immune thrombocytopenia., PMID:35815383
• [Research progress of vascular endothelial growth factor-A and its isoforms in kidney disease]., PMID:35199126
• Life and Death of Podocytes: Not Only a Matter of Vascular Endothelial Growth Factor., PMID:26930245
• Preface., PMID:30612609
• Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock., PMID:37781371
• Diabetic retinopathy., PMID:22784133
• Diabetic retinopathy., PMID:22784134
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Bioactivity

    SEC-HPLC detection for Research Grade Tefibazumab.

  • SDS-PAGE

    SDS-PAGE for Research Grade Tefibazumab.

References
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list